UH Rainbow Neonatologists Evaluating Common Nutritional Supplement as Protective Against Alcohol Exposure Among NICU Infants

Share
Facebook
X
Pinterest
LinkedIn
Email
Print
Nurses hand holding neonatal baby foot in incubator.

Innovations in Pediatrics | Fall 2026

A neonatology team from UH Rainbow Babies & Children’s has secured a prestigious R01 grant from the National Institutes of Health to expand their research on the role of alcohol exposure in apnea of prematurity – and the potential role of choline in mitigating it.

Apnea of prematurity is a common ailment of early preterm infants, with more than 60,000 infants experiencing the condition each year in the United States. It’s characterized by episodic cessation of breathing and often accompanied by intermittent hypoxemia, which is linked to poor neurodevelopmental outcomes.

Cynthia Bearer, MD, PhDCynthia Bearer, MD, PhD
Peter MacFarlane, PhDPeter MacFarlane, PhD

“These premature babies should still be in the womb, where they're getting oxygen from the placenta and getting rid of carbon dioxide through the placenta,” says principal investigator Cynthia Bearer, MD, PhD, Division Chief of Neonatology at UH Rainbow and William and Lois Briggs Chair in Neonatology, University Hospitals, and Professor of Pediatrics at Case Western Reserve University School of Medicine. “But the parts of the brain that make them breathe aren't fully mature. These babies in the NICU can have gaps in their breathing, or they'll drop their heart rate in response to the hypoxia, or they'll drop their oxygen saturations. This is an important issue that keeps babies in the NICU for longer periods. It sometimes is the only reason why we're waiting to send them home.”

Dr. Bearer, working with fellow UH Rainbow neonatology researcher Peter MacFarlane, PhD, Director of Neonatology Basic Research and the William and Lois Briggs Research Chair in Neonatology, UH Rainbow, and Associate Professor at the School of Medicine, hypothesizes that preterm infants who are exposed to ethanol as an excipient in NICU-administered medications are at increased risk of these problems – and that choline may be protective of this effect.

“We use quite a few drugs that have alcohol as an excipient,” she says. “Preterm infants are also exposed to other sources of alcohol. Hand sanitizer is 67% alcohol. It evaporates on your hands, which is why we use it, but all that alcohol evaporates into the airspace, which can be within the isolette of the baby. Therefore, there may be several ways that preterm infants are exposed.”

In previous NIH-funded research, Dr. Bearer has developed evidence to support her alcohol-apnea-choline hypothesis.

“In our rat model, we have shown that very low doses of alcohol, lower than what a baby might be exposed to, does increase their dysfunctional respiratory control,” she says.

Specifically, Dr. Bearer and her research team have shown that ethanol disrupts the function of a lipid raft-associated protein, both in vitro and ex vivo, and alters cerebellar-mediated behaviors. They’ve also shown that choline confers resistance to the effects of ethanol on both the lipid raft-associated protein and behaviors.

With this new grant, she and Dr. MacFarlane are further probing this line of inquiry.

“We hypothesize that ethanol disrupts control of respiration, ion channel function, and lipid rafts leading to perturbations in the nucleus tractus solitarius -- one of the main areas of the brainstem that controls respiration,” she says.

There’s reason to believe that choline may be protective against this process, Dr. Bearer says.

“We’ve shown in previous studies that if we supplement our rat pups with choline, they don't have as much respiratory dysfunction as they do in the absence of choline,” she says. “We’re pursuing the idea of whether choline administration or supplementation to our rat pups is going to improve their resilience to the effects of this ethanol. We hypothesize that choline, a known neuroprotectant, reduces the impact of ethanol on both respiratory drive, ion channel function and lipid rafts.”

Dr. Bearer says she hopes the team’s work will ultimately lead to clinical trials using choline to further reduce apnea and the morbidity associated with ethanol exposure in preterm infants. Choline has the advantage, she says, of being a convenient method of nutritional supplementation.

She says she also hopes the team’s research will promote the removal of alcohol from medications given to preterm infants.

”We're hoping that more medications will go ethanol-free,” she says. “The medication maybe can be ground up and given as a slurry down the NG tube. It doesn't have to be solubilized. Most of these are oral medications that contain the ethanol, so they could be done in that way.”

A third goal is to make people aware that these NICU babies are choline deficient – with enormous implications for the developing brain.

“Most moms are choline-deficient, and babies in the NICU are choline-deficient,” Dr. Bearer says. ”We hope to see an increasing, public health push to incorporate choline into some of the prenatal vitamins that pregnant women get.”

“The whole tamale would be making sure that the public gets enough choline, the same way they do with folic acid, where it’s added to common foods,” she adds. “It’s the way we make sure we get iodine and calcium and folic acid. I think choline ought to be on that list.”

Contributing Experts: Cynthia Bearer, MD, PhD, Peter MacFarlane, PhD

Share
Facebook
X
Pinterest
LinkedIn
Email
Print